{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:48:51Z","timestamp":1792900131368,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CureHHT Foundation","award":["CureHHT Foundation"],"award-info":[{"award-number":["CureHHT Foundation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the considerable burden that hereditary hemorrhagic telangiectasia (HHT) imposes, few studies have investigated its effect on health-related quality of life (HRQoL). We aimed to assess the impact of HHT on psychosocial QoL and identify demographic and clinical factors associated with lower QoL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted an international, cross-sectional study of 1042 adults with HHT within the Cure HHT network, between 2022 and 2023. We used an online survey that included 5 standardized instruments to evaluate patients\u2019 perceptions of the impact of HHT on their QoL: Epistaxis Severity Score (ESS); Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE-HHT); Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue \u2013 Short Form 8a \u2013 Fatigue interfere scale (PROMIS-Fatigue 8a); Hospital Anxiety and Depression Scale (HADS-A and HADS-D); and Short Form Health Survey (SF-36). Statistical analyses included Spearman\u2019s correlations, univariate analyses, Tukey\u2019s honestly significant difference, and Kruskal-Wallis tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>565\/1042 (54%) participants completed the survey. The most common symptoms were epistaxis 521\/565 (92%) and fatigue 446\/565 (79%). There were strong positive correlations between HADS-A and ESS (2.6 [95% CI 1.7\u20133.6]) and NOSE-HHT (4 [3.2-5]); HADS-D and ESS (1.4 [1.3\u20131.5]) and NOSE-HHT (4.4 [3.4\u20135.7]); PROMIS Fatigue 8a and ESS (8.2 [6.3\u201310]) and NOSE-HHT (5.9 [5.2\u20136.6]); and SF-36 scores and ESS (\u2212\u200926.4 [\u2212\u200933 to \u2212\u200919.9]) and NOSE-HHT (\u2212\u200933.1 [\u2212\u200939.7 to \u2212\u200928.6]). Liver failure and seizures indicated a higher likelihood of depression (3.1 [1-5.2]), anxiety (3 [0.6\u20135.4]), and fatigue (9.6 [4.7\u201314.5]). Seizures were associated with depression (2.9 [1.8\u20133.9]), anxiety (2.9 [1.7\u20134.1]), and fatigue (5 [2.34\u20137.7]). Participants expressed a substantial effect on their physical (143\/560 [25%]), role (140\/556 [25%]), emotional (124\/554 [22%]), social (104\/556 [18%]), and cognitive (64\/550 [11%]) functioning. However, more participants considered extremely important to improve their physical (289\/560 [51%]), cognitive (266\/550 [47%]), role (253\/556 [43%]), emotional (243\/554 [45%]), and social (233\/556 [41%]) functioning affected by HHT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Severe epistaxis is associated with higher rates of depression, anxiety, and fatigue. Participants expressed desire for improvement in a broad range of functional domains disturbed by HHT. This suggests a need for increased awareness, resources, and more effective interventions to improve the QOL of patients with HHT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03620-8","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:12:32Z","timestamp":1741349552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quantifying the burden of hereditary hemorrhagic telangiectasia on quality of life and psychological health: a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Anna J.","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisabel Linares","family":"Bolsegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek C.","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2180-1731","authenticated-orcid":false,"given":"Clifford R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"3620_CR1","unstructured":"McDonald J, Stevenson DA et al. Hereditary Hemorrhagic Telangiectasia. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2023 Feb 12]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1351\/"},{"key":"3620_CR2","unstructured":"Locke T, Gollamudi J, Chen P. Hereditary Hemorrhagic Telangiectasia (HHT). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Feb 12]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK578186\/"},{"key":"3620_CR3","doi-asserted-by":"crossref","unstructured":"Bayrak-Toydemir P, Mao R, Lewin S, McDonald J. Hereditary hemorrhagic telangiectasia: An overview of diagnosis and management in the molecular era for clinicians. Genet Med [Internet]. 2004 [cited 2023 Jun 9];6:175\u201391. Available from: https:\/\/www.nature.com\/articles\/gim200439","DOI":"10.1097\/01.GIM.0000132689.25644.7C"},{"key":"3620_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13023-017-0632-2","volume":"12","author":"MM Serra","year":"2017","unstructured":"Serra MM, Besada CH, Cabana Cal A, Saenz A, Stefani CV, Bauso D, et al. Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2017;12:92.","journal-title":"Orphanet J Rare Dis"},{"key":"3620_CR5","first-page":"477","volume":"19","author":"RK Fulbright","year":"1998","unstructured":"Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998;19:477\u201384.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3620_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13023-022-02426-2","volume":"17","author":"TTT Le","year":"2022","unstructured":"Le TTT, Martinent G, Dupuis-Girod S, Parrot A, Contis A, Riviere S, et al. Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT. Orphanet J Rare Dis. 2022;17:281.","journal-title":"Orphanet J Rare Dis"},{"key":"3620_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/JAC.0000000000000262","volume":"42","author":"AJ Selim","year":"2019","unstructured":"Selim AJ, Qian SX, Rogers W, Arya D, Simmons K, Shapiro GD, et al. Health status in adults with chronic conditions: intervention strategies for improving Patient-Reported outcomes. J Ambul Care Manage. 2019;42:2\u201320.","journal-title":"J Ambul Care Manage"},{"key":"3620_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/clpt.2011.195","volume":"90","author":"NE Rothrock","year":"2011","unstructured":"Rothrock NE, Kaiser KA, Cella D. Developing a valid patient-reported outcome measure. Clin Pharmacol Ther. 2011;90:737\u201342.","journal-title":"Clin Pharmacol Ther"},{"key":"3620_CR9","unstructured":"Kotronoulas G, Maguire R, Harrow A, Di Domenico D, Croy S, Kearney N. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. [cited 2023 Mar 14]; Available from: https:\/\/core.ac.uk\/reader\/158368143?utm_source=linkout"},{"key":"3620_CR10","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4081\/hpr.2013.932","volume":"1","author":"K Megari","year":"2013","unstructured":"Megari K. Quality of life in chronic disease patients. Health Psychol Res. 2013;1:e27\u201327.","journal-title":"Health Psychol Res"},{"key":"3620_CR11","doi-asserted-by":"publisher","unstructured":"Martinent G, Carrot M, Chirac A, Dupuis-Girod S, Fargeton A-E, Blois Da Concei\u00e7\u00e3o S et al. Hereditary hemorrhagic telangiectasia and health-related quality of life: a qualitative investigation. Qual Life Res [Internet]. 2020 [cited 2023 May 26];29:1291\u20139. Available from: https:\/\/doi.org\/10.1007\/s11136-020-02415-7","DOI":"10.1007\/s11136-020-02415-7"},{"key":"3620_CR12","doi-asserted-by":"crossref","unstructured":"Zarrabeitia R, Fari\u00f1as-\u00c1lvarez C, Santib\u00e1\u00f1ez M, Se\u00f1aris B, Fontalba A, Botella LM et al. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT). Health Qual Life Outcomes [Internet]. 2017 [cited 2023 May 24];15:19. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5259834\/","DOI":"10.1186\/s12955-017-0586-z"},{"key":"3620_CR13","doi-asserted-by":"crossref","unstructured":"Geisthoff UW, Heckmann K, D\u2019Amelio R, Gr\u00fcnewald S, Kn\u00f6bber D, Falkai P et al. Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngology - Head and Neck Surgery [Internet]. 2007 [cited 2023 May 24];136:726.e1-726.e10. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0194599806036060","DOI":"10.1016\/j.otohns.2006.12.019"},{"key":"3620_CR14","doi-asserted-by":"publisher","unstructured":"Merlo CA, Yin LX, Hoag JB, Mitchell SE, Reh DD. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. International Forum of Allergy & Rhinology [Internet]. 2014 [cited 2023 Feb 17];4:921\u20135. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/alr.21374","DOI":"10.1002\/alr.21374"},{"key":"3620_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91:66\u20137.","journal-title":"Am J Med Genet"},{"key":"3620_CR16","unstructured":"Cross-sectional, survey study measuring Health Related Quality of Life (HRQOL.) of patients with Hereditary Hemorrhagic Telangiectasia [Internet]. CureHHT. [cited 2023 May 24]. Available from: https:\/\/curehht.org\/research_project\/hopkins-hht-hrqol-tool\/"},{"key":"3620_CR17","doi-asserted-by":"crossref","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Medicine [Internet]. 2016 [cited 2024 Apr 18];4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5052926\/","DOI":"10.1177\/2050312116671725"},{"key":"3620_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM, O\u2019Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160\u20134.","journal-title":"BMJ"},{"key":"3620_CR19","doi-asserted-by":"publisher","unstructured":"Gong AJ, Bolsegui ML, Lee EE, Mathai SC, Weiss CR. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test\u2013Retest Reliability. Am J Rhinol?Allergy [Internet]. 2024 [cited 2024 Mar 25];38:38\u201346. Available from: http:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/19458924231207137","DOI":"10.1177\/19458924231207137"},{"key":"3620_CR20","doi-asserted-by":"publisher","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. The Laryngoscope [Internet]. 2010 [cited 2023 Feb 3];120:838\u201343. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/lary.20818","DOI":"10.1002\/lary.20818"},{"key":"3620_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamaoto.2020.3040","volume":"146","author":"AM Peterson","year":"2020","unstructured":"Peterson AM, Kallogjeri D, Spitznagel E, Chakinala MM, Schneider JS, Piccirillo JF. Development and validation of the nasal outcome score for epistaxis in hereditary hemorrhagic telangiectasia (NOSE HHT). JAMA Otolaryngol Head Neck Surg. 2020;146:999\u20131005.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3620_CR22","doi-asserted-by":"publisher","unstructured":"Cook KF, Bamer AM, Roddey TS, Kraft GH, Kim J, Amtmann D. A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Qual Life Res [Internet]. 2012 [cited 2024 Feb 8];21:1021\u201330. Available from: https:\/\/doi.org\/10.1007\/s11136-011-0011-8","DOI":"10.1007\/s11136-011-0011-8"},{"key":"3620_CR23","doi-asserted-by":"publisher","unstructured":"Terwee CB, Elsman EB, Roorda LD. Towards standardization of fatigue measurement: Psychometric properties and reference values of the PROMIS Fatigue item bank in the Dutch general population. Research Methods in Medicine & Health Sciences [Internet]. 2022 [cited 2024 Feb 8];3:86\u201398. Available from: https:\/\/doi.org\/10.1177\/26320843221089628","DOI":"10.1177\/26320843221089628"},{"key":"3620_CR24","doi-asserted-by":"crossref","unstructured":"Bartlett SJ, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Ginsberg S et al. Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis. Quality of Life Research [Internet]. 2018 [cited 2024 Feb 8];27:2443\u201351. Available from: https:\/\/www.jstor.org\/stable\/44856487","DOI":"10.1007\/s11136-018-1880-x"},{"key":"3620_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69\u201377.","journal-title":"J Psychosom Res"},{"key":"3620_CR26","doi-asserted-by":"publisher","unstructured":"Stern AF. The Hospital Anxiety and Depression Scale. Occupational Medicine [Internet]. 2014 [cited 2023 May 31];64:393\u20134. Available from: https:\/\/doi.org\/10.1093\/occmed\/kqu024","DOI":"10.1093\/occmed\/kqu024"},{"key":"3620_CR27","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing. 2021. Available from: https:\/\/www.R-project.org\/"},{"key":"3620_CR28","unstructured":"Home. - GraphPad [Internet]. [cited 2023 Oct 30]. Available from: https:\/\/www.graphpad.com\/"},{"key":"3620_CR29","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s11136-004-7865-y","volume":"13","author":"G Pasculli","year":"2004","unstructured":"Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabb\u00e0 C. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res. 2004;13:1715\u201323.","journal-title":"Qual Life Res"},{"key":"3620_CR30","doi-asserted-by":"crossref","unstructured":"Loa\u00ebc M, Moriniere S, Hitier M, Ferrant O, Plauchu H, Babin E. Psychosocial quality of life in hereditary haemorrhagic telangiectasia patients. Rhin [Internet]. 2011 [cited 2023 May 24];49:164\u20137. Available from: https:\/\/www.rhinologyjournal.com\/Abstract.php?id=968","DOI":"10.4193\/Rhino10.090"},{"key":"3620_CR31","doi-asserted-by":"crossref","unstructured":"Kasthuri RS, Chaturvedi S, Thomas S, Vandergrift N, Bann C, Schaefer N et al. Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument. Blood Advances [Internet]. 2022 [cited 2023 May 24];6:4301\u20139. Available from: https:\/\/ashpublications.org\/bloodadvances\/article\/6\/14\/4301\/485436\/Development-and-performance-of-a-hereditary","DOI":"10.1182\/bloodadvances.2022007748"},{"key":"3620_CR32","unstructured":"EQ-5D-3L Health Questionnaire [Internet]. EuroQol Research Foundation. [cited 2022 Jul 13]. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-3l-about\/"},{"key":"3620_CR33","doi-asserted-by":"publisher","unstructured":"Pierucci P, Lenato GM, Suppressa P, Lastella P, Triggiani V, Valerio R et al. A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study. Orphanet Journal of Rare Diseases [Internet]. 2012 [cited 2023 Jun 9];7:33. Available from: https:\/\/doi.org\/10.1186\/1750-1172-7-33","DOI":"10.1186\/1750-1172-7-33"},{"key":"3620_CR34","doi-asserted-by":"publisher","first-page":"E591","DOI":"10.1002\/ajh.24832","volume":"92","author":"RS Kasthuri","year":"2017","unstructured":"Kasthuri RS, Montifar M, Nelson J, Kim H, Lawton MT, Faughnan ME, et al. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia. Am J Hematol. 2017;92:E591\u20133.","journal-title":"Am J Hematol"},{"key":"3620_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1023\/A:1008978114650","volume":"9","author":"AJ Patterson","year":"2000","unstructured":"Patterson AJ, Brown WJ, Powers JR, Roberts DCK. Iron deficiency, general health and fatigue: results from the Australian longitudinal study on women\u2019s health. Qual Life Res. 2000;9:491\u20137.","journal-title":"Qual Life Res"},{"key":"3620_CR36","doi-asserted-by":"publisher","unstructured":"Hoag JB, Merlo CA. Health-related quality of life in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. D69 Exercise in Health and Disease [Internet]. American Thoracic Society; 2010 [cited 2023 Oct 9]. pp. A6486\u2013A6486. Available from: https:\/\/www.atsjournals.org\/doi\/abs\/https:\/\/doi.org\/10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A6486","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A6486"},{"key":"3620_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/194589240501900112","volume":"19","author":"PA Lennox","year":"2005","unstructured":"Lennox PA, Hitchings AE, Lund VJ, Howard DJ. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol. 2005;19:71\u20134.","journal-title":"Am J Rhinol"},{"key":"3620_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/00019053-200220150-00002","volume":"20","author":"P Berto","year":"2002","unstructured":"Berto P. Quality of life in patients with epilepsy and impact of treatments. PharmacoEconomics. 2002;20:1039\u201359.","journal-title":"PharmacoEconomics"},{"key":"3620_CR39","doi-asserted-by":"publisher","unstructured":"Sajobi TT, Josephson CB, Sawatzky R, Wang M, Lawal O, Patten SB et al. Quality of Life in Epilepsy: Same questions, but different meaning to different people. Epilepsia [Internet]. 2021 [cited 2023 Jul 18];62:2094\u2013102. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1111\/epi.17012","DOI":"10.1111\/epi.17012"},{"key":"3620_CR40","doi-asserted-by":"crossref","unstructured":"Heyworth IT, Hazell ML, Linehan MF, Frank TL. How do common chronic conditions affect health-related quality of life? Br J Gen Pract [Internet]. 2009 [cited 2023 Oct 19];59:e353\u20138. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2765853\/","DOI":"10.3399\/bjgp09X453990"},{"key":"3620_CR41","doi-asserted-by":"crossref","unstructured":"Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart [Internet]. 2002 [cited 2023 Jul 19];87:235\u201341. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1767036\/","DOI":"10.1136\/heart.87.3.235"},{"key":"3620_CR42","unstructured":"Masaki Hayama Y, Maeda T, Shikina S, Tatehara G, Inokuchi JB, Hoag et al. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan| Elsevier Enhanced Reader [Internet]. [cited 2023 Feb 16]. Available from: https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S0385814621002650?token=5D67C24FEE26F13FF2BC8D5A860868C938EA85EE9F223B3965F3587529DD188A3446371F09915572E889E563876E269B%26originRegion=us-east-1%26originCreation=20230216153349"},{"key":"3620_CR43","doi-asserted-by":"crossref","unstructured":"Larson AM. Liver Disease in Hereditary Hemorrhagic Telangiectasia. Journal of Clinical Gastroenterology [Internet]. 2003 [cited 2023 Jun 15];36:149. Available from: https:\/\/journals.lww.com\/jcge\/Abstract\/2003\/02000\/Liver_Disease_in_Hereditary_Hemorrhagic.13.aspx","DOI":"10.1097\/00004836-200302000-00013"},{"key":"3620_CR44","doi-asserted-by":"publisher","unstructured":"Nagel M, Labenz C, W\u00f6rns MA, Marquardt JU, Galle PR, Schattenberg JM et al. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives. Health and Quality of Life Outcomes [Internet]. 2020 [cited 2023 Jul 18];18:10. Available from: https:\/\/doi.org\/10.1186\/s12955-019-1268-9","DOI":"10.1186\/s12955-019-1268-9"},{"key":"3620_CR45","doi-asserted-by":"crossref","unstructured":"Danesino C, Cantarini C, Olivieri C. Hereditary Hemorrhagic Telangiectasia in Pediatric Age: Focus on Genetics and Diagnosis. Pediatr Rep [Internet]. 2023 [cited 2024 Apr 18];15:129\u201342. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9944132\/","DOI":"10.3390\/pediatric15010011"},{"key":"3620_CR46","unstructured":"Geirdal A\u00d8, Dheyauldeen S, Bachmann-Harildstad G et al. Living with hereditary haemorrhagic telangiectasia: Coping and psychological distress \u2013 A cross-sectional study [Internet]. [cited 2023 Jun 7]. Available from: https:\/\/www.tandfonline.com\/doi\/epdf\/10.3109\/09638288.2012.690500?needAccess=true&role=button."},{"key":"3620_CR47","doi-asserted-by":"crossref","unstructured":"Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics Part A [Internet]. 2010 [cited 2023 Jun 7];152A:1136\u201356. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ajmg.a.33380","DOI":"10.1002\/ajmg.a.33380"},{"key":"3620_CR48","doi-asserted-by":"publisher","unstructured":"Mora-Luj\u00e1n JM, Iriarte A, Alba E, S\u00e1nchez-Corral MA, Cerd\u00e0 P, Cruellas F et al. Gender differences in hereditary hemorrhagic telangiectasia severity. Orphanet Journal of Rare Diseases [Internet]. 2020 [cited 2023 Jul 19];15:63. Available from: https:\/\/doi.org\/10.1186\/s13023-020-1337-5","DOI":"10.1186\/s13023-020-1337-5"},{"key":"3620_CR49","doi-asserted-by":"publisher","unstructured":"Fodor E, Lane L, Schippers J, van der Lippe T. Gender Differences in Quality of Life. In: B\u00e4ck-Wiklund M, van der Lippe T, den Dulk L, Doorne-Huiskes A, editors. Quality of Life and Work in Europe: Theory, Practice and Policy [Internet]. London: Palgrave Macmillan UK; 2011 [cited 2023 Jun 7]. pp. 149\u201361. Available from: https:\/\/doi.org\/10.1057\/9780230299443_9","DOI":"10.1057\/9780230299443_9"},{"key":"3620_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1037\/0278-6133.10.2.86","volume":"10","author":"RM Kaplan","year":"1991","unstructured":"Kaplan RM, Anderson JP, Wingard DL. Gender differences in health-related quality of life. Health Psychol. 1991;10:86\u201393.","journal-title":"Health Psychol"},{"key":"3620_CR51","doi-asserted-by":"crossref","unstructured":"Galiatsatos P, Wilson C, O\u2019Brien J, Gong AJ, Angiolillo D, Johnson J et al. A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy. Orphanet J Rare Dis [Internet]. 2022 [cited 2023 Jun 7];17:220. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9195340\/","DOI":"10.1186\/s13023-022-02371-0"},{"key":"3620_CR52","doi-asserted-by":"crossref","unstructured":"Yusuf H, Rasheed A, Kim H, Conrad MB, Hetts SW. Identifying Racial disparities in hereditary hemorrhagic telangiectasia. J Neurointerv Surg. 2022;neurintsurg-2022-019162. Available from: https:\/\/jnis.bmj.com\/content\/15\/10\/1050.long.","DOI":"10.1136\/jnis-2022-019162"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03620-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:12:47Z","timestamp":1741349567000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03620-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3620"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03620-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of The Johns Hopkins Medical institutions, and all recruitment and data collection procedures were performed following the relevant ethical standards. Written informed consent has been obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that all authors have approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}